🔎 Trials Near Me

Почетна › Гојазност › Оклахома

Kliničke studije za Гојазност u državi Оклахома

18 studija za Гојазност traži učesnike na lokacijama u državi Оклахома.

Gradovi u državi Оклахома

Zvanični tekst studije (na engleskom)

Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight

  • Epic Medical Research - Oklahoma, Chickasha
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 9. 11. 2026. · NCT07871409

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • Delricht Research of Tulsa Clinical Trials, Tulsa
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351045

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Lynn Institute of Norman, Norman
  • Lynn Health Science Institute, Oklahoma City
  • Essential Medical Research, Tulsa
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351058

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

  • Epic Medical Research - Oklahoma, Chickasha
  • Lynn Health Science Institute, Oklahoma City
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 6. 11. 2026. · NCT07575399

A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)

  • AMR Clinical, Norman
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07919678

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • Central States Research, Tulsa
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07794579

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  • Central States Research, Tulsa
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07353931

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • University of Oklahoma Health Sciences Center, Oklahoma City
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 4. 11. 2026. · NCT06672549

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  • Alliance for Multispecialty Research, LLC, Norman
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT06897475

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  • Research Site, Tulsa
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07784725

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

  • Lynn Health Science Institute, Oklahoma City
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 26. 10. 2026. · NCT07837973

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Moore
  • ACCOMPLISH-2 Research Site, Tulsa
  • ACCOMPLISH-2 Research Site, Yukon
Тражи се учесникФаза 3Здраве особе су добродошле
Узраст од 18 до 79 · Оба пола · Ажурирано 20. 10. 2026. · NCT07654374

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

  • University of Oklahoma, Norman
Тражи се учесник
Узраст од 18 до 45 · Жене · Ажурирано 16. 10. 2026. · NCT05124808

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Alliance for Multispecialty Research - Norman, Norman
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 5. 10. 2026. · NCT07684235

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

  • Children's Physicians OU, Oklahoma City
Тражи се учесникФаза 3
Узраст од 8 до 18 · Оба пола · Ажурирано 30. 9. 2026. · NCT07253285

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

  • Lynn Institute of Norman, Norman
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT07720271

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Oklahoma City
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743450

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

  • ACCOMPLISH-1 Research Site, Moore
Тражи се учесникФаза 3
Узраст од 18 до 79 · Оба пола · Ажурирано 10. 8. 2026. · NCT07654361

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.